
News|Articles|July 1, 2010
Formulary Digital Edition, July 2010
Hemophilia: Etiology, complications, and current options in management; Rifaximin: A nonabsorbable, broad-spectrum antibiotic for reduction in the risk for recurrence of overt hepatic encephalopathy; Agents in late-stage development for the treatment of female and male cancers
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
4 things to know about the Abarca/LucyRx merger
2
FDA approves Skinvive to address horizontal neck wrinkles, “tech neck”
3
Healthcare's AI push is creating a new workforce challenge
4
Hospitals facing financial headwinds can't afford to ignore the mounting threats to 340B
5
































